Equity Overview
Price & Market Data
Price: $0.0661
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $106,470,672
Daily Volume: 0
Performance Metrics
1 Week: 55.53%
1 Month: 55.53%
3 Months: 55.53%
6 Months: 55.53%
1 Year: -43.98%
YTD: %
Details
Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; and AI program, a novel drug discovery therapies for the treatment of influenza and respiratory syncytial viruses. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.